| | | | | SAN JOSE, Calif. (Reuters) - At its Silicon Valley headquarters, network gear maker Cisco Systems Inc is going to unusual lengths to take control of the relentless increase in its U.S. healthcare costs. | | |
| | | LONDON (Reuters) - A gene-editing technology that is being explored by scientists worldwide as a way of removing and replacing gene defects might inadvertently increase cancer risk in cells, scientists warned on Monday. | | |
| | | (Reuters Health) - As the costs of medical school and training continue to rise, young surgeons often face debt burdens that make it difficult for them to start their careers and pay off their loans, according to a new study. | | |
| | | (Reuters Health) - Very few U.S. adults receive all the preventive health care services recommended for them, reports a new study. | | |
| | | LOS ANGELES (Reuters) - Billionaire Patrick Soon-Shiong plans to take an experimental cancer treatment company public this year and has begun hiring bankers, the biotechnology entrepreneur told Reuters. | | |
| | | (Reuters Health) - Health benefits claimed by marketers of sex robots - safer sex, therapeutic possibilities, and the potential to treat pedophiles and sex offenders - haven't been proven, or even well studied, experts say. | | |
| | | (Reuters Health) - Each year, U.S. adults with high blood pressure incur almost $2,000 more in annual healthcare costs, according to a new study | | |
| | | (Reuters) - Medical device maker Stryker Corp has made a takeover approach to rival Boston Scientific Corp, the Wall Street Journal reported on Monday, a combination that would give Stryker a strong position in stroke-preventing heart products. | | |
| | | LONDON (Reuters) - The mother of an epileptic boy who journeyed to Canada to buy cannabis-based medication she says is keeping her son alive had her supplies confiscated by British customs officials upon her return on Monday. | | |
| | | (Reuters) - Allergan Plc said on Monday its oral migraine drug met the main goal across all doses in a study, with a statistically significant reduction in monthly headache days in patients with episodic migraine. | | |
|
| |
